Lymphoma microenvironment: culprit or innocent?

被引：56

作者：

Herreros, B. ^{[1
]}

Sanchez-Aguilera, A. ^{[1
]}

Piris, M. A. ^{[1
]}

机构：

[1] CNIO, Spanish Natl Canc Ctr, Mol Pathol Program, Lymphoma Grp, Madrid 28029, Spain

来源：

LEUKEMIA | 2008年 / 22卷 / 01期

关键词：

lymphoma microenvironment; BCR signaling; BAFF/APRIL; CD40; chemokines;

D O I：

10.1038/sj.leu.2404970

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Studies are revealing that lymphoid neoplasms are characterized by well-defined chromosome translocations and by the accumulation of subsequent molecular alterations involving mainly the cell cycle and/or apoptotic pathways. However, survival of B and T tumor cells is also dependent on the interactions with the accompanying cells that comprise the lymphoma microenvironment. Although non-tumor cells can contribute both positive and negative signals to the lymphoma cells, in this review we present compelling evidence of the essential influence of the tumor microenvironment on the initiation and progression of specific lymphoma types, highlighting some new therapeutic approaches that target the lymphoma microenvironment.

引用

页码：49 / 58

页数：10

共 116 条

[1] T-cell/histiocyte-rich B-cell lymphoma: Biology, diagnosis, and management [J].

Abramson, Jeremy S. .

ONCOLOGIST, 2006, 11 (04) :384-392

[2]

Aizawa S, 1997, J BIOL CHEM, V272, P2042

[3] Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms [J].

Al-Saleem, T ;

Al-Mondhiry, H .

BLOOD, 2005, 105 (06) :2274-2280

[4] Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells [J].

Aldinucci, D ;

Lorenzon, D ;

Olivo, K ;

Rapanà, B ;

Gattei, V .

LEUKEMIA & LYMPHOMA, 2004, 45 (09) :1731-1739

[5] Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course [J].

Algara, P ;

Mateo, MS ;

Sanchez-Beato, M ;

Mollejo, M ;

Navas, IC ;

Romero, L ;

Solé, F ;

Salido, M ;

Florensa, L ;

Martínez, P ;

Campo, E ;

Piris, MA .

BLOOD, 2002, 99 (04) :1299-1304

[6] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[7] Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells [J].

Alvaro, T ;

Lejeune, M ;

Salvadó, MT ;

Bosch, R ;

García, JF ;

Jaén, J ;

Banham, AH ;

Roncador, G ;

Montalbán, C ;

Piris, MA .

CLINICAL CANCER RESEARCH, 2005, 11 (04) :1467-1473

[8]

Alvaro T, 2006, HAEMATOLOGICA, V91, P1605

[9] Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection [J].

Ambrosetti, A ;

Zanotti, R ;

Pattaro, C ;

Lenzi, L ;

Chilosi, M ;

Caramaschi, P ;

Arcaini, L ;

Pasini, F ;

Biasi, D ;

Orlandi, E ;

D'Adda, M ;

Lucioni, M ;

Pizzolo, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (01) :43-49

[10] Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease [J].

Axdorph, U ;

Porwit-MacDonald, A ;

Grimfors, G ;

Björkholm, M .

LEUKEMIA & LYMPHOMA, 2001, 42 (05) :1055-+

← 1 2 3 4 5 6 7 8 9 10 →